Indolent & Transformed Lymphoma
Outcomes
Updated: May 2011
Click on the thumbnails below to view full-size images.
Indolent Lymphoma Allo SCT
Lightbox JS v2.0 | Test Page
Indolent Lymphoma Auto SCT
Lightbox JS v2.0 | Test Page
Transformed Lymphoma General
Lightbox JS v2.0 | Test Page
Transformed Lymphoma Auto SCT
Lightbox JS v2.0 | Test Page
Transformed Lymphoma - Impact of Pre-SCT Rituxan Therapy
Lightbox JS v2.0 | Test Page
Transformed Lymphoma Allo SCT
Lightbox JS v2.0 | Test Page
| The information contained in these guidelines is a statement of consensus of Leukemia/BMT Program of BC professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient’s care or treatment. Use of these guidelines and documents is at your own risk and is subject to the Leukemia/BMT Program of BC’s terms of use available at Terms of Use. |